Allerfen

Quick links to important sections

Allerfen

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Allerfen

Quick Facts

Property Description
Active ingredient Fexofenadine hydrochloride
Form Tablet, Oral suspension, Film-coated tablet
Pharmacological class Second-generation antihistamine
Common use Relief from allergic symptoms
Origin Synthetic (Piperidine derivative)

Defining Allerfen: Type, Composition, and Origin

Allerfen is a brand name for a medicine whose active ingredient is Fexofenadine hydrochloride, a synthesized, single-ingredient compound. The medicine is formally classified as a second-generation antihistamine, functioning as a Histamine H1 receptor antagonist. This classification confirms its role as an antiallergic agent used to manage the physical symptoms arising from allergic responses.

Chemically, Fexofenadine is a synthetic piperidine derivative, which is pharmacologically significant because it functions as the major active metabolite of the older antihistamine terfenadine. This chemical evolution provides a targeted approach, being widely recognized for its improved safety profile compared to its precursor. It is formulated as a single active ingredient product intended for oral administration.


What Kind of Antihistamine is Fexofenadine?

Fexofenadine is distinguished as a peripheral selective H1 antagonist, meaning its action is concentrated primarily in tissues outside the central nervous system. This selectivity is the basis for its identity as a non-sedating antihistamine.

The drug is specifically designed to minimally cross the blood-brain barrier (BBB), which is crucial to preventing the widespread cognitive effects of older antihistamines. Fexofenadine does not significantly impair central nervous system function, ensuring that it can alleviate symptoms without causing associated severe drowsiness.


Forms and General Purpose of Allerfen

The active ingredient Fexofenadine is prepared for oral intake and is commonly available in several dosage forms, including the tablet and an oral suspension. The overarching general purpose of the medicine is to provide relief from the physical manifestations of an allergic reaction. By acting as a histamine blocker, its primary benefit is alleviating the general discomfort associated with common allergic symptoms, such as sneezing, itching, and the skin irritation characteristic of chronic urticaria.

Regulatory References

  1. NIH MedlinePlus Drug Information

What side effects are possible with Allerfen?

Possible Side Effects and Safety Information

The safety profile of Allerfen (Fexofenadine hydrochloride) is based strictly on data from clinical trials and post-marketing surveillance, as documented in regulatory prescribing information.

Documented Adverse Reactions

The most frequently reported side effects in clinical trials—many of which occurred at rates similar to placebo—are classified by regulatory agencies as Common:

  • Headache
  • Drowsiness, Dizziness
  • Nausea, Stomach Discomfort
  • Back Pain, Pain in Extremity

Uncommon side effects include fatigue. A wide range of other reactions, such as insomnia, nervousness, tachycardia (fast heart rate), palpitations, pruritus (itching), and rash, have been reported during post-marketing surveillance, and their frequency is classified as Not Known.

Serious Adverse Reactions

The official labeling documents the potential for serious, immediate Hypersensitivity Reactions (severe allergic responses). These are important identified risks and may manifest as:

  • Angioedema (swelling beneath the skin)
  • Anaphylaxis (systemic allergic reaction)
  • Chest tightness or Dyspnoea (shortness of breath)

Safety Considerations for Specific Populations

Safety statements address variations in specific patient groups:

  • Renal Impairment: Patients with decreased kidney function require cautious use as the drug's elimination half-life is increased, and dose adjustments are necessary.
  • Older Adults: Increased sensitivity may be a factor, and caution is advised.
  • Cardiovascular Disease: Individuals with a history of cardiovascular issues should be aware of the documented potential for tachycardia and palpitations.

Safety-Related Restrictions

The medicine is contraindicated in individuals with a known hypersensitivity to fexofenadine or its inactive ingredients. Furthermore, official labeling notes that the simultaneous intake of fruit juices (grapefruit, apple, orange) and antacids containing aluminum or magnesium hydroxide may reduce the absorption of fexofenadine.

Overdose and Emergency Response

Overdose and when to seek help

The following information details the official overdose profile for Allerfen (Fexofenadine), strictly as documented in government regulatory sources.


Overdose Scope

Documented overdose presentations: Symptoms officially reported in cases of acute overdosage include drowsiness (somnolence), dizziness, dry mouth, and fatigue.
Physiological systems affected: Manifestations primarily affect the Central Nervous System.
Dose-related or exposure-related factors: Regulatory documents note that information regarding the signs and symptoms of Fexofenadine overdose is limited.
Population-specific overdose notes: No specific population-based management differences (e.g., for pediatric or renally impaired patients) are explicitly detailed in the official overdose sections.
Emergency-response statements: Contact the Poison Control Helpline immediately or seek assistance from a doctor or nearest hospital emergency department.
When immediate medical help is required: Immediate medical assistance is required if the person has collapsed, experienced a seizure, has trouble breathing, or cannot be awakened (loss of consciousness). Urgent help should be sought even without immediate signs of discomfort.

Resulting Overdose Structure

Official overdose statements:

  • The recommended management approach is symptomatic and supportive treatment.
  • Measures to remove any unabsorbed drug should be considered.
  • Hemodialysis is not effective for removing Fexofenadine and provides no clinical benefit.

Connection to the overall overdose profile: Official regulatory documents define the overdose profile primarily by minor central nervous system effects, leading to required immediate contact with the Poison Control Helpline or a physician. For severe, escalating signs such as seizure or collapse, contacting emergency services is mandated. The clinical procedures documented in official labels affirm that no specific antidote is known.

Therapeutic Uses of Allerfen

Allerfen (Fexofenadine hydrochloride) is commonly used as a supportive therapeutic option in conditions characterized by heightened, disruptive allergic symptoms. Its application is relevant for easing symptomatic discomfort across relevant therapeutic domains, and it may assist patients in coping with symptomatic periods. The medication is considered relevant across domains where additional symptomatic support is needed for systemic or localized discomfort.

The medication is commonly used to help with the symptomatic management of Seasonal Allergic Rhinitis (hay fever) and Chronic Idiopathic Urticaria (CIU). It is applied during phases when symptoms become more noticeable, and is relevant for easing symptom clusters that may become intense or disruptive, such as frequent sneezing, bothersome runny nose, and intense itchy eyes or skin. In this context, the goal of treatment is supportive:

“Symptomatic assistance with Allerfen may help patients cope more steadily with symptom fluctuations when acute manifestations create noticeable interference with daily activities and comfort.”

This approach is helpful in situations requiring additional symptomatic assistance, as it contributes to improved day-to-day comfort during periods of heightened symptoms.


Quick Fact: Relief for Allergic Symptom Clusters

Symptom Domain Common Manifestations Addressed Relevant Clinical Scenarios
Respiratory/Ocular Sneezing, runny nose, itchy/watery eyes Seasonal or year-round allergen exposure
Dermatologic Hives (wheals), widespread skin itching (pruritus) Recurrent or chronic flare-ups of urticaria

Regulatory References

  1. NIH MedlinePlus overview on Fexofenadine

Eligibility and Restrictions for Use

This section summarizes the official population eligibility and restriction rules for using Allerfen (fexofenadine), as defined in government regulatory labeling.

Eligibility Scope

Classification Population Group Regulatory Status
Absolute Contraindication Patients with known hypersensitivity to fexofenadine or its excipients. Must Not Use
Established Use Adults and adolescents ge 12 years of age. Allowed
Children aged 6 to 11 years. Allowed
Children ge 6 months (for specific liquid formulations and indications). Allowed
Conditional Use Patients with decreased renal function. Caution (Dose adjustment required)
Patients with hepatic impairment. Caution
Older adults (ge 65 years). Caution (Monitoring for renal function)
Not Recommended Women who are pregnant. Not Recommended (Limited data)
Women who are breastfeeding/lactating. Not Recommended (Excreted in milk)

Resulting Eligibility Structure

Regulatory documents establish that Allerfen is contraindicated only by known hypersensitivity to the drug. Eligibility for use is broadly defined by age-based thresholds, permitting use in adults and children down to six months for specific liquid formulations. For special populations, such as those with renal impairment, hepatic impairment, or pre-existing cardiovascular disease, use is classified as conditional or requires specific caution. The medicine is not recommended for women who are pregnant or breastfeeding, reflecting limited or non-conclusive safety data in these groups.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory information outlines several categories of substances that may interact with Allerfen (fexofenadine), primarily affecting the drug's absorption or cardiac safety profile.

Substances Affecting Drug Exposure

Interacting Substance Category Official Statement on Consequence
Antacids (Aluminum & Magnesium Hydroxide) Reduced absorption of Allerfen.
Fruit Juice (e.g., Apple, Grapefruit, Orange) May impair absorption of Allerfen; should not be taken together.

Substances Affecting Safety Profile

  • Potentially Arrhythmogenic Drugs: Concomitant use with drugs liable to interfere with hepatic metabolism or those that prolong the QT interval may lead to potentially hazardous ventricular arrhythmias.
  • Electrolyte Imbalance Agents: Co-administration with drugs likely to cause electrolyte imbalance (e.g., hypokalemia) requires caution.
  • Sedatives and Alcohol: While sedative interactions apply to a lesser extent, excessive alcohol consumption should be avoided.

Procedural and Population Notes

  • Allergen Skin Testing: Allerfen may suppress the cutaneous histamine response to allergen extracts and must be stopped several days before skin testing to ensure valid results.
  • Renal Impairment: Caution is required in patients with renal impairment due to the prolonged elimination half-life, which may increase drug exposure.

Mechanism of Action

How Allerfen Works: Mechanism of Action

Allerfen's action is defined by its selective binding to Peripheral Histamine H1 receptors, primarily acting as an inverse agonist. This molecular interaction stabilizes the receptor in its inactive conformation, competitively preventing endogenous histamine from binding and activating the cell.

The stabilization of the H1 receptor interrupts the Histamine-Mediated Inflammatory Pathway by blocking the cellular signaling cascade, including G-protein coupling. This modification of the cellular sequence translates into the modulation of microvascular permeability in peripheral tissues.

The resulting physiological consequence is the effect on the flow of fluid and protein across capillary walls. This occurs as the mechanism influences cell junctions, reducing extravasation into the surrounding tissue. Allerfen's biological influence is target-specific, engaging pathways determined solely by the histamine system.

Dosage and Administration Information

How Allerfen is Used: Administration Guidelines

Allerfen (fexofenadine hydrochloride) is administered via the oral route in its dosage forms, which include the tablet, oral suspension, and oral disintegrating tablet (ODT). Use involves following specific instructions concerning dosage, frequency, and conditions of intake.


Standard Dosing and Frequency

Patient Population Standard Dose Frequency Maximum Daily Dose
Adults ( 12 years) 60 mg OR 180 mg Twice daily OR Once daily (180 mg) 180 mg
Pediatric (6–11 years) 30 mg Twice daily 60 mg
Pediatric (6 months–< 2 years) 15 mg (suspension only) Twice daily 30 mg

Administration Conditions and Adjustments

Special Instructions for Intake:

The medicine should be taken with water. To ensure appropriate absorption, fexofenadine tablets must not be taken with fruit juices, including grapefruit, apple, or orange juice. Tablets should be swallowed whole without chewing.

Population-Specific Dosing:

Specific dosage reductions apply for patients with decreased kidney function (renal impairment). The starting dose for adults and adolescents ( 12 years) is reduced to 60 mg once daily, and the dose for children (6–11 years) is reduced to 30 mg once daily. No specific dose adjustment is generally required for patients with liver impairment.

Recent Clinical Evidence

Research Evidence / Overview of studies for Allerfen


Evidence for use in Seasonal Allergic Rhinitis (SAR)

Research examined Allerfen (fexofenadine) in studies monitoring symptoms of Seasonal Allergic Rhinitis (SAR), commonly known as hay fever. The evidence base consists primarily of short-term, randomized, double-blind, placebo-controlled clinical trials (RCTs). These studies were used in research exploring how symptoms change over defined time intervals.

The outcomes monitored included a Total Symptom Score and scores for symptoms such as sneezing, rhinorrhea (runny nose), and ocular (eye) itching. The evidence, including systematic reviews and meta-analyses, describes the changes in measurements for these common allergy symptoms observed during the study period.

Evidence for use in Chronic Idiopathic Urticaria (CIU)

Studies examined Allerfen within the research context of Chronic Idiopathic Urticaria (CIU), a condition characterized by fluctuating or episodic manifestations such as chronic hives. The primary evidence supporting this use comes from randomized, controlled clinical trials. The research explored short-term changes by monitoring symptoms during episodes of heightened activity.

These studies monitored two key outcomes related to the condition: the intensity of itching (pruritus score) and the daily number of wheals (wheal count). Findings describe patterns observed in the studies, including measurements reported for the severity of itching and the number of hives.


Evidence Gaps and Areas of Uncertainty

The research highlights what is known—and what is still uncertain—about Allerfen. One key research limitation is that the long-term effects are not fully established, as the core clinical trials utilized limited follow-up durations. This reflects the existing research limitation regarding how symptoms may evolve over many months or years of use. Additionally, while children were studied, the available data for certain pediatric subgroups remain limited, and subgroup findings are uncertain.

Key Studies & References

  1. Fexofenadine: Drug Information (NIH MedlinePlus)

Frequently Asked Questions (FAQ)

Common questions about Allerfen (FAQ)

Q: How quickly does Allerfen start working?

Official regulatory studies show that the antihistamine effect of fexofenadine typically begins within 60 minutes of taking a dose. The drug's maximum effect, measured by the reduction in symptoms, is generally observed within two to three hours.

Q: Can Allerfen be taken with food?

Regulatory guidance for some dosage forms describes taking the medicine before a meal. This is because certain foods, particularly high-fat meals, have been documented to potentially reduce the amount of fexofenadine absorbed by the body.

Q: Do you need a prescription to get Allerfen?

The availability of fexofenadine varies significantly depending on the region and the dose being considered. In many countries, certain strengths or forms are available over-the-counter (OTC) without a prescription, while in other areas, a prescription may be required.

Q: How long does the effect of Allerfen last?

Clinical studies examining the drug's action indicate that the antihistaminic effect of fexofenadine is maintained for up to 24 hours after an administered dose. This duration supports the once-daily dosing frequency for certain strengths.

Q: What happens if I miss a time to take Allerfen?

Regulatory patient information describes the general guidance for a missed dose as taking it as soon as it is remembered. When it is nearly time for the next scheduled dose, the information states that the missed dose should be skipped, and the regular schedule continued.

Q: Does Allerfen lose effectiveness over time?

Studies examining fexofenadine use over short periods, such as 28 days, found no evidence of tolerance, which would suggest a loss of effectiveness over time.

Q: Are there generic versions of Allerfen available?

Yes, the active ingredient in Allerfen, fexofenadine hydrochloride, has been approved by regulatory bodies in multiple jurisdictions for generic versions.

Q: What research is currently being done on Allerfen?

Research efforts continue to explore the drug's full profile and potential applications beyond its approved uses for allergic rhinitis and urticaria. Studies, often supported by governmental research institutions, have been conducted to examine its effect on specific inflammatory pathways in the body.

Q: Is Allerfen suitable for treating non-seasonal allergies?

While fexofenadine is officially indicated for the relief of symptoms associated with Seasonal Allergic Rhinitis (hay fever), some medical literature also describes its use in alleviating the symptoms of Perennial Allergic Rhinitis, which is a non-seasonal type of allergy.

Q: Do any official documents describe Allerfen as 'strong'?

Official regulatory and scientific documents describe fexofenadine by its pharmacological classification, such as a selective H1 receptor antagonist. These official texts focus on verifiable clinical data, such as symptom score reduction and duration of effect, and do not use subjective or comparative terminology like 'strong' or 'weak.'

Q: What should I do if I experience a potential side effect from Allerfen?

Patient information from regulatory sources describes the process of reporting any concerning symptoms to a healthcare professional. For symptoms classified as serious, such as difficulty breathing, swelling beneath the skin (angioedema), or signs of a severe allergic reaction, the information indicates that immediate medical attention is necessary.

Q: Does Allerfen interact with common pain relievers?

Official patient guidelines indicate that fexofenadine may generally be taken at the same time as common pain relievers. This includes non-prescription medicines such as paracetamol and ibuprofen.

Q: Is there a link between Allerfen and changes in mood?

Official regulatory adverse event reports classify nervousness as a potential reaction reported after the drug was marketed (frequency is not known). However, formal regulatory documents do not list general 'changes in mood' such as depression or anxiety as a common or uncommon side effect.

Q: Does the time of day matter when taking Allerfen?

Regulatory instructions specify the frequency (such as once or twice daily) and the conditions of intake (such as before a meal) for fexofenadine. However, official information does not prescribe a specific time of day—like morning or evening—based on the patient's biological clock.

Q: Can Allerfen be taken at the same time as supplements?

Official patient guidelines state that comprehensive information is often not available to confirm potential interactions between fexofenadine and many general herbal remedies or supplements.

Q: What is the official safety classification of Allerfen?

The formal safety classification of fexofenadine for use in special populations, such as during pregnancy, is determined by regulatory agencies on a regional basis. For example, the Australian regulatory body classifies fexofenadine as a Category B2 medicine.

Q: Are there weight restrictions for taking Allerfen?

Official regulatory documents define the standard dosing for fexofenadine based on a patient's age and specific health conditions, such as kidney function. The instructions do not define dosage restrictions or adjustments based on an individual's body weight.

Q: Is Allerfen known to interact with blood pressure medication?

While official documents do not list specific classes of blood pressure medication as having a definite interaction, regulatory warnings advise caution for individuals with a history of cardiovascular disease. This caution is based on the general knowledge that antihistamines, as a class, have been associated with reported events like tachycardia (fast heart rate) and palpitations.

Q: How long after stopping Allerfen does it stay in your system?

Pharmacokinetic data from regulatory documents shows that the mean terminal elimination half-life of fexofenadine is approximately 11 to 15 hours in healthy adults. This half-life is the time it takes for the concentration of the drug in the body to be reduced by half.

Q: Why is Allerfen sometimes used for non-allergy symptoms?

Regulatory approval for fexofenadine is strictly granted for its established uses, which include the relief of symptoms associated with specific allergic conditions like Seasonal Allergic Rhinitis and Chronic Idiopathic Urticaria. Any other potential uses are not officially established or supported by regulatory documents.

Q: Is Allerfen safe to use for a long period of time?

Studies have examined the administration of fexofenadine for periods lasting up to one year in clinical trials. During these specific study periods, the research found no clinically significant increase in adverse events compared to placebo.

Q: What is the difference between Allerfen and other popular allergy pills?

Official classifications define fexofenadine as a second-generation antihistamine. It is a peripheral selective H1 antagonist, meaning it primarily acts outside the central nervous system. This selectivity is the basis for its distinction as having a lower potential for drowsiness compared to older antihistamines.

Q: Is Allerfen considered safe for the elderly?

Regulatory documents advise caution when fexofenadine is administered to older adults because available clinical data in this population is considered limited. The need for monitoring, particularly for kidney function, is noted in the official guidance.

Q: Does Allerfen treat the cause or just the symptoms of allergies?

The documented mechanism of action involves blocking the cellular effect of histamine on receptors, which is the substance responsible for allergy symptoms. Therefore, the drug works by providing relief from the physical manifestations of the allergy, and does not treat the underlying immune cause of the allergic response itself.

Q: Is Allerfen a long-acting formulation?

Clinical studies indicate that the antihistamine effect of fexofenadine can last for up to 24 hours following administration of the recommended dose. The duration of effect supports the use of certain strengths as a once-daily treatment for allergic symptoms.

How should Allerfen be stored and disposed of?

Storage Conditions and Handling

Official regulatory guidelines require that Allerfen (Fexofenadine hydrochloride) tablets be stored at Controlled Room Temperature, typically 20 C to 25 C (68 F to 77 F). The medicine must be kept in its original, tightly closed container and protected from both excessive moisture and high heat. It must not be frozen and should not be stored in high-humidity areas, such as a bathroom.

Disposal and Child Safety

Allerfen must always be stored out of the sight and reach of children. Unused or expired medicine should not be disposed of in the trash or flushed down a drain to prevent environmental contamination. Instead, the product must be discarded via an authorized drug take-back program or by consulting a pharmacist for official disposal guidance.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Allerfen found in:

A-Z Index: